- Report
- October 2024
- 197 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 93 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- January 2025
- 134 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- October 2024
- 145 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- October 2024
- 110 Pages
United States
From €5415EUR$5,950USD£4,642GBP
- Report
- May 2023
- 187 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- February 2024
- 113 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- May 2023
- 107 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- April 2024
- 132 Pages
Global
From €865EUR$950USD£741GBP
The Pharmaceutical Analytical Testing Outsourcing market is a subset of the Drug Discovery industry, which involves the development of new drugs and treatments. It is a highly specialized field that requires a range of analytical testing services to ensure the safety and efficacy of new drugs. Outsourcing these services to specialized companies can help reduce costs and speed up the drug development process.
Analytical testing services include a range of activities such as method development and validation, stability testing, impurity profiling, and bioanalytical testing. These services are essential for ensuring the quality and safety of new drugs, and for meeting regulatory requirements.
Companies in the Pharmaceutical Analytical Testing Outsourcing market include Eurofins Scientific, SGS, Intertek, Charles River Laboratories, and WuXi AppTec. Show Less Read more
